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Abstract Simulation using Monte Carlo code has been conducted to determine the distribution of absorbed dose to the 
breast brachytherapy with 131Cs and 103Pd radionuclide sources. Simulations performed on stage I breast cancer with 
cancer diameter is 2 cm. Sources of radionuclides simulated in the form of seed is modeled with CS-1 which is made by 
IsoRay 131Cs and seed ADVANTAGETM 103Pd which is made by IsoAID, LLC. Seed was planted in breast cancer cells. 
Calculation of absorbed dose distribution was performed by varying the distance from the seed. Variations of the distance 
started from a radius of 0.3 cm to 2 cm with a range of 0.1 cm respectively. In this simulation will also be reviewed the 
value of absorbed dose for healthy cell like breast, sternum, and lung. The relation between the absorbed dose and the 
distance from the seed can be described in the form of power law. The results of the calculation show that the maximum 
absorbed dose is in the target site of the cancer cells (5.791 ± 0.002) Gy per 5 MBq of 131Cs and (2.755 ± 0.009) Gy per 5 
MBq for 103Pd. The absorbed dose at sternum (1.514 ± 0.011) x 10-4 Gy per 5 MBq of 131Cs and (7.515 ± 0.633) x 10-7 
Gy per 5 MBq for 103Pd. While the absorbed dose in the lungs is and (3.615 ± 0.082) x 10-5 Gy per 5 MBq for 131Cs and 
(3.972 ± 0.591) x 10-8 Gy per 5 MBq for 103Pd. 
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INTRODUCTION 
A. Background 
One of malignant disease that often 
affects women is breast cancer. There are 
several choices of breast cancer treatment, and 
of course this choice depends on the size and 
location of the tumor [1]. 
Breast cancer is defined as a disease of 
malignant neoplasms that originate from the 
parenchyma [2]. If breast cancer is still in stage 
I and II, then one of the early stages of 
overcoming breast cancer is surgery or called 
lumpectomy. Cancer cells are composed of 
abnormal cells that grow in certain tissues and 
cells remain roots can continue to grow 
uncontrolled [3]. To that end, after surgery 
patients are encouraged to do radiation therapy 
that aims weeks to kill cancer cells in the removal 
of the tumor and the surrounding area. 
Brachytherapy an alternative therapy 
treatment of cancer through electromagnetic 
radiation from a radioactive substance placed 
near the cancer cells [4]. This method is an 
effective procedure to kill cancer cells and to 
prevent tumor coming back. Type of 
radionuclides commonly used in breast 
Brachytherapy is 192Ir, 103Pd and 131Cs [5]. 
One method is a method of breast 
Brachytherapy MHDR (Mammosite High Dose 
Rate Brachytherapy System). This method uses 
the type of radionuclide iridium (192Ir) which is 
inserted into the balloon catheter. Treatment with 
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MHDR method is limited in patients who 
already had a lumpectomy space as a balloon 
catheter, so that patients with early stage can 
not be taken care of by methods MHDR. To 
overcome this, other methods that can be used 
is a method PBSI (Permanent Seed Implant 
Breast). PBSI method uses a radioactive 
substance that shaped capsule (seed) which is 
implanted in cancer cells permanently until the 
maximum dose is reached. Patients in the early 
stages can be treated with metoe PBSI without 
surgical removal of tissue [6]. 
Determination of safe dose to specific 
organs in Brachytherapy very important to 
note. During this time of dosing implants using 
a simple way by using the approach in tumor 
shape and form of radionuclide sources. The 
approach is often done, tumor volume is 
assumed to be a block or ball, and radionuclide 
sources is assumed as the point form so that the 
absorbed dose obtained is not right. Possibility 
to put detectors and radioactive substances in 
the body simultaneously extremely unlikely 
that the necessary simulations to calculate the 
absorbed dose as precisely as possible. Monte 
Carlo method is one program that can be used 
to define the function of dose distributions, 
dose variation and dose calculations for 
Brachytherapy [7]. 
Information dose distribution in the 
tumor needs to be known by a medical 
physicist to do so when therapy healthy tissue 
around the tumor dose is minimal. Departing 
from the background of the writer wanted to 
know the distribution of micro-capsule dose 
radionuclide 131Cs source and 103Pd on breast 
cells and the surrounding healthy tissue. 
B. Review of Literature 
Brachy derived from the Greek 
"brachios" which means close, linguistically 
Brachytherapy can be interpreted as a therapeutic 
range. The term was later used for the application 
of radiation therapy from close range to 
Brachytherapy of the term is radiation therapy 
with radiation sources close to the source of the 
disease. This treatment method is often also 
called the closed-source radiation therapy 
(internal) or sealed source [8]. 
Application of the method Brachytherapy 
need to pay attention to the distribution of 
radiation dose at close range as interstitial, 
intracavitary or intravascular. The amount of 
radiation dose used carefully arranged so that the 
tumor and surrounding normal tissue to get the 
planned dose [4]. 
Interstitial Brachytherapy is one technique 
Brachytherapy by inserting a radiation source in 
cancer tissue. Implantation in an organ using a 
needle or catheter applicator [8]. Intracavitary 
Brachytherapy a radiation therapy by inserting a 
contact applicator through the lumen (cavity of 
the body) which will then be filled with sources 
of radionuclides for example 192Ir [9]. 
Mammosite High Dose Rate Brachytherapy 
System (MHDR) is one of the techniques 
intracavitary Brachytherapy. Patients with the 
application of techniques MHDR first undergo 
surgical removal of the cancerous tissue 
(lumpectomy). The next stage is inserting a 
balloon catheter into a chamber containing 192Ir 
lumpectomy. The use of this method is limited to 
patients who have cancer tissue removed and can 
not be used for cancer in its early stages. 
Obstacles faced with MHDR methods can 
be overcome using a technique interstitial 
Brachytherapy by planting a seed that already 
contains the source of radionuclides into the 
organs of the body through a catheter. One of the 
methods of the technique known as Permanent 
Seed Implant Breast (PBSI) [10]. 
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PBSI treatment process with this method 
takes ± 60 minutes and not only done one time 
treatment but is done according to the level of 
damage as a result of breast cancer cells. 
Planting seed will be guided using CT-Scan 
and ultrasound. 
Implant Brachytherapy effective only if 
all parts of the visible tumor. Tumors can be 
accessed and the limit is clear enough. Tumors 
were great and boundless invisible 
Brachytherapy usually not done because it is 
difficult to reach the edges of the tumor [10]. 
Application of Brachytherapy technique 
can overcome weaknesses in radiotherapy that 
do not focus on targets who are at risk of 
surrounding healthy tissue. Implementation is 
done by first estimating quantitative biological 
effects on patients. The biological effects of 
Brachytherapy can be known accurately in 
terms of physical quantity which is the energy 
absorbed by each unit mass of tissue. 
Studies have been conducted PBSI 
adapting the method using Monte Carlo 
software to calculate the absorbed dose to the 
breast Brachytherapy. The first study using 
125I source as a seed planted in the breast. The 
distribution of the absorbed dose is obtained an 
effect on other organs such as the heart and 
spine. The experts then look for other sources 
of radioanuklida more appropriate to replace 
125I [5]. 
Other studies using 103Pd which has a 
lower energy than 125I and a shorter half-life. 
Based on the research that has been done, use 
103Pd relatively safe because the distribution of 
absorbed dose in organs other than the breast 
is relatively small compared to the use of 125I. 
Organ breast scores absorbed dose of 90 Gy, 
other organs such as the lungs, sternum and 
heart are affected only by ± 5 Gy [11]. In 2011 
also has simulated determination of γ-radiation 
absorbed dose using radionuclide sources 103Pd to 
know the effect of absorbed dose to the breast 
tissue, lung and chest bone. Seed implant 
assumed as dots that spreads the breast tissue. The 
Pengasumsian less relevant because in fact the 
seed implant shaped capsule with a radioactive 
substance in it [6]. Additionally absorbed dose is 
measured on average around breast cells 
regardless of the absorbed dose distribution 
around the seed. 
In the year 2012 has made the development 
of research preceding year with seed implants 
made previously in the form of a point into a 
capsule shape with a cylindrical geometry as a 
cover source coupled with the base and lid 
hemispherical corresponding to the shape of seed 
ADVANTAGE™ 103Pd. Capsule seed 
ADVANTAGE™ 103Pd created by isoAID LLC 
[6]. Pengasumsian form of seed, pendefisian 
source of radionuclides in seed and seed position 
in the breast cells are less precise so that the 
modeling does not meet the reality. 
In addition 103Pd radionuclide sources, in 
2004 the source of the radionuclide 131Cs was also 
introduced to the medical world, especially for 
Brachytherapy. Radionuclide 131Cs higher energy 
and has a shorter half-life than the average of 
other isotopes commonly used in breast 
Brachytherapy like 103Pd and 125I [12]. Monte 
Carlo simulations using software to radionuclide 
131Cs source is still limited. The study uses micro-
capsules 131Cs (model Cs-1) was conducted to 
determine the distribution of dose on the prostate 
organs and surrounding healthy tissue [13]. 
Measurements of dose distributions with MCNP 
program showed satisfactory results with 
accuracy error of less than 5%. 
Based on the insights and background 
libraries that have been previously described, it 
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will be absorbed dose distribution 
measurement on Brachytherapy breast, lung 
and breast bone with 131Cs seed sources and 
103Pd. It is intended to determine the pattern of 
Distribution of the dose, so that could be a 
reference to the treatment of breast 
Brachytherapy so that treatment can be run 
safely. 
RESEARCH METHODS 
This study begins by gathering 
information and data related to the issues to be 
discussed are searching for the study of 
geometry ORNL-MIRD, characteristic of 
131Cs and 103Pd through library of papers, 
theses, books, diktat and from the internet. 
In solving the problems, this study is 
divided into several sections, namely; 
A. Modeling Geometry 
The first step in this research is the 
geometry modeling ADVANTAGETM 103Pd 
seed, seed CS-1 131Cs, cancer cells using a 
variation of the distance, breast tissue, lung 
and breast bone of the data previously 
collected. Geometry modeling begins with 
making the card surface which is the surface 
appearance of the model geometry. Making the 
card followed by cell surface card that contains 
specifications covering the space between the 
surface density of the material, material 
definitions, and the name of each cell. 
Afterwards, cell importance is to be calculated 
and defined sources of radiation used and 
continued to command the election tally. 
Modelling distance variation performed 
in the range of 0.3 cm to 2 cm from seed, 
phantom geometry modeling geometry 
adapted to the shape, density and volume of 
adult female phantom models ORNL-MIRD 
while modeling Radionuclide Sources indicated 
by Table I as follows: 
Table. 1. Radionuclide sources Input 
 
Description 
 Radionuklida Sources 
103Pd 131Cs 
Shape 
Capsule 
ADVANTAGE™ 
models 
Capsule CS-1 
models 
Total seed 1 piece 1 piece 
Half-life 16,99 days 9,6 days 
Energiy 0,021 MeV 0,0304 MeV 
emission of 
particles 
Photon Photon 
Placement 
source 
In breast cancer 
cells 
In breast cancer 
cells 
 
Definition of resources required to simulate 
a trip particles. In this simulation the radiation 
source in the form of micro capsules implanted in 
breast cancer cells. Definition of resources 
needed as input MCNPX execution is kind of the 
emitted particles, energy, abundance of particles, 
particle beam direction, and geometry in the form 
of radionuclide source shape position. 
B. Verification Modeling Results 
Verification is done by displaying the 
geometry created in a two-dimensional look and 
can also be displayed in three dimensions. Seed 
modeling results, variations in distance and 
phantom shown in Figure 1, Figure 2, Figure 3, 
Figure 4 and Figure 5 as follows. 
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 Figure 1. Seed 131Cs 
Model Cs-1 capsule 131Cs has received 
permission from the FDA in 2003. The capsule 
diameter of 0.8 mm with a length of 4.5 mm. 
Figure 1 shows a model of Cs-1 capsule from 
IsoRay 131Cs. 
 
Figure 2. Seed 103Pd 
Figure 2 is a geometry Seed 103Pd 
ADVANTAGE™ models which refers to the 
model geometry belongs isoAID LLC. The 
outside diameter of the capsule of 0.8 mm with 
a length of 4.5 mm. 
 
Figure 3. Distance Variations from Seed 
Figure 3 shows the variation of the 
distance spherical cell cancer of the seed 
planted in the breast. In this simulation 
modeling is also conducted to review the value 
of healthy tissue around the breast absorbed dose 
in order to get value of absorbed dose to a 
minimum. Modeling healthy tissue can be seen in 
Figure 3 below: 
  
Figure 4. Geometry Phantom body. 
In this study, the radionuclide source 
modeling cylindrical form of micro capsules. 
Modeling adapted to the shape and size of the 
originals and not assumed to be a point so that the 
information absorbed dose in the radius direction 
adjacent to the seed also needs to be known. The 
modeling is done by dividing cancer cells that are 
close to the seed into four pieces at a radius of 0.3 
cm to 0.6 cm from seed as shown in Figure 5 
below: 
 
Figure 5. Geometry Cell Cancer in Four Parts 
Also shown the results of plot and plot 
tracks the source to determine the position of the 
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particle source of radionuclides in cell 
geometry seed that has been made and the 
direction of the particle distribution. 
C. Determine Source of Variation Activities 
NPS card (Number of Photon per Secon) 
is the input source of the radionuclide activity. 
Variations NPS is 1 x 106 NPS; 2 x 106 NPS; 
3 x 106 NPS; 4 x 106 NPS; 5 x 106 NPS. The 
amount of NPS will set a specific number of 
particles that live right on the number of NPS 
is entered. 
D. Execution Program 
Execution is to get the value of Energy 
Deposition (Mev/Trans) which would then be 
converted to the value of absorbed dose. In this 
simulation running time is stopped using the 
NPS card which is a variation of the source 
activity. The whole treatment is applied to all 
the variations and the circuit has been 
modeled. 
RESULTS AND DISCUSSION 
Execution of the program has been 
successfully carried out and the results of 
running the data obtained by the 
transformation of energy deposition 
(MeV/Trans). These results are then converted 
into units of absorbed dose to get the value of 
each cell. The result of the calculation of 
absorbed dose distribution is shown in Table II 
and Table III as follows: 
Table II Absorbed Dose Distribution of 131Cs 5 
MBq 
Radionuclides Sources 131Cs 
R (cm) Absorbed Dose (Gy) Information 
0,3 5,791 ± 0,002 cancer cells 
0,4 1,756 ± 0,008 cancer cells 
0,5 1,051 ± 0,005 cancer cells 
0,6 (6,939 ± 0,039) x 10-1 cancer cells 
0,7 (4,913 ± 0,024) x 10-1 cancer cells 
0,8 (3,650 ± 0,012) x 10-1 cancer cells 
0,9 (2,840 ± 0,011) x 10-1 cancer cells 
1 (2,235 ± 0,017) x 10-1 cancer cells 
- (1,514 ± 0,011) x 10-4 Sternum 
- (3,615 ± 0,082) x 10-5 Lungs 
 
Tabel III Absorbed Dose Distribution of 103Pd 5 MBq 
Radionuclides Sources 103Pd 
R (cm) Absorbed Dose (Gy) Information 
0,3 2,755 ± 0,009 cancer cells 
0,4 (7,967 ± 0,044) x10-1 cancer cells 
0,5 (4,437 ± 0,034) x 10-1 cancer cells 
0,6 (2,813 ± 0,021) x 10-1 cancer cells 
0,7 (1,885 ± 0,016) x 10-1 cancer cells 
0,8 (1,345 ± 0,013) x 10-1 cancer cells 
0,9 (9,759 ± 0,066) x 10-2 cancer cells 
1 (7,286 ± 0,058) x 10-2 cancer cells 
- (7,515 ± 0,633) x 10-7 Sternum 
- (3,972 ± 0,591) x 10-8 Lungs 
 
 
From Table II and Table III can be graphed 
the relationship between the dose absorbed by 
variations in the distance from the source shown 
in Figure 6. 
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Figure 6. Relationship Between the distance with 
Absorbed Dose. 
From Figure 6 it can be seen that the 
magnitude of the dose absorbed decreasing 
power law of the distance from the source. 
This happens because the photon energy 
generated is reduced or absorbed by the 
material through which it passes i.e. cancer 
cells. Due to the absorption of energy by the 
cancer cells, the intensity of the photon will be 
reduced after passing the cancer cells. The 
energy that is absorbed is called the absorbed 
dose. Based on the results obtained, the 
distribution of absorbed dose to the maximum 
dose contained in a radius of 0.3 cm from the 
seed to the absorbed dose of (5.791 ± 0.002) 
Gy per 5 MBq of 131Cs and (2.755 ± 0.009) Gy 
per 5 MBq for 103Pd while the minimum dose 
contained in the organ around the breast that is 
to be reviewed on the sternum of (1.514 ± 
0.011) x 10-4 Gy per 5 MBq of 131Cs and 
(7.515 ± 0.633) x 10-7 Gy per 5 MBq for 103Pd. 
As for lung 131Cs absorbed dose obtained by 
(3.615 ± 0.082) x 10-5 Gy per 5 MBq and (3.97 
± 0.5) x 10-8 Gy per 5 MBq for 103Pd. Value 
relative error at the output MCNPX tally refers 
to the type of one sigma confidence level (1σ) 
with the correct percentage of 68.5%. From the 
simulation results can be concluded that the 
risk Brachytherapy to injure other organs is very 
small. 
In the area of the ball is close to the seed 
occurs absorbed dose distribution is uneven due 
to the cylindrical shape of the seed. Subsequent 
research carried out for the calculation of the 
direction distribution of dose distributions by 
dividing the area into four sections ball. Quadrant 
1 shows the upper region of the seed, quadrant 2 
shows the right-side area of the seed, third 
quadrant shows the lower region of the seed, and 
quadrant 4 shows left side area of the seed. The 
result of the calculation of dose distributions 
obtained are shown in Table 5.3 as follows, 
Tabel IV. Distribution Dosage in close distance from 
Seed. 
103Cs Source  103Pd Source 
Radius 0,3 cm Radius 0,3 cm 
Information dose (%) Information dose (%) 
Quadrant 1 20,67% Quadrant 1 19,57% 
Quadrant 2 29,30% Quadrant 2 30,76% 
Quadrant 3 20,79% Quadrant 3 20,16% 
Quadrant 4 29,24% Quadrant 4 29,51% 
total 100% total 100% 
 
The data in Table IV shows that the 
percentage distribution of absorbed dose 
distribution direction at a radius of 0.3 cm highest 
one is in quadrant 2 and quadrant 4 which is the 
right and left of the seed. This is because the area 
in quadrant 2 and 4 closer to the source. 
In this study, the absorbed dose distribution 
calculation with five variations of activity for 
each radionuclide sources shown in Figure 7 and 
Figure 8 as follows: 
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Figure 7. 131Cs Source 
Figure 8. 103Pd Source 
The results showed that the absorbed 
dose increases with the increase given activity. 
The relationship between the activity of the 
absorbed dose can be used to obtain the 
optimal dose. The maximum optimal dosing in 
breast Brachytherapy note to kill cancer cells. 
The maximum dose calculations will be 
discussed further in the next section. 
The radiation dose depends on the 
amount of energy deposited or absorbed by 
materials, activities, duration of radiation, and 
the distance of the source to the target. The 
maximum dose to kill cancer cells in the breast 
Brachytherapy is equal to 90 Gy [10]. Before 
calculating the maximum dose, the first known 
absorbed dose relationship with the activity of the 
radionuclide. The relationship between the dose 
absorbed by the activity shown in Figure 9 as 
follows: 
 
Figure 9. The relationship between dose Absorbed 
with Activities. 
Activities seed source is an activity that is 
used in units of the NPS (Number of photons per 
second). The amount of resources activity can be 
increased by increasing the NPS at the input. NPS 
is defined as the number of particles γ decay per 
second (Bq). In Figure 9 is shown that the greater 
the activity that is used, the greater the value of 
absorbed dose. Can be concluded that the dose 
absorbed is linearly related to the total activity of 
each radionuclide is implanted. Linear 
relationship occurs because of radiation used is 
homogeneous. Homogeneous means that the 
radiation source used is the same that 131Cs with 
0.0304 MeV energy and to 103Pd at 0.021 MeV. 
With the equation in Figure 9 it is to achieve 
the optimum dose can be done by raising 
activities. If y is a function of absorbed dose, x is 
the activity of seed used and y = 90 Gy, then the 
value obtained for x amounted to 77.56 MBq 
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131Cs and x for 103Pd amounted to 163.34 
MBq for single capsule. The result of the 
calculation of the maximum activity data 
obtained can then be used to review the 
maximum absorbed dose received by healthy 
tissue sternum and lungs. The review was 
conducted by program execution back and 
enter the appropriate value in the input NPS 
activity data in order to obtain the maximum 
value of absorbed dose to healthy tissue 
sternum and lungs. The results obtained from 
the calculation, the value of absorbed dose to 
the sternum of 2.35 × 10-3 Gy and the lungs of 
5.49 × 10-4 Gy of 131Cs, while the absorbed 
dose to 103Pd obtained on the sternum by 2, Gy 
and 45 × 10-5 and in the lungs of 1.29 × 10-6 
Gy. Values absorbed dose received by healthy 
tissue is relatively small and are under the 
tolerance dose TD5/5 17.5 Gy to the lung, 
whereas tolerated dose to the breast bone is not 
presented yet absorbed dose obtained 
relatively very small even when compared 
with the dose tolerance for society. From the 
calculation of the maximum activity showed 
that the 131Cs to have a better role than the 
103Pd in killing cancer cells, this is due to the 
maximum activity required by 131Cs to provide 
the same biological effect on tumor cells 
smaller than the 103Pd. 
CONCLUSION 
In this study it can be concluded on the 
dose distribution in the breast Brachytherapy 
including; 
1. Distribution of absorbed dose from 
seed centers around breast cancer decreased 
power law with increasing radius of cancer 
cells. From the resulting distribution of 
absorbed dose obtained maximum dose 
contained in a radius of 0.3 cm from the seed to 
the absorbed dose of (5.791 ± 0.002) Gy per 5 
MBq of 131Cs and (2.755 ± 0.009) Gy per 5 MBq 
for 103Pd. The minimum dose contained in the 
sternum was (1.514 ± 0.011) x 10-4 Gy per 5 
MBq of 131Cs and and (7.515 ± 0.633) x 10-7 Gy 
per 5 MBq for 103Pd. As for lung 131Cs absorbed 
dose obtained by (3.615 ± 0.082) x 10-5 Gy per 5 
MBq and (3.972 ± 0.591) x 10-8 Gy per 5 MBq 
for 103Pd. 
2. There was an absorbed dose distribution 
is uneven in cancer cells closest to the seed with 
the greatest percentage of doses are in quadrant 2 
and quadrant 4 which is the right side and the left 
side of the seed. 
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